The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
Sign in to access this content
Sign InCentene Corp. reported robust financial results for 2025, highlighting a successful recovery driven by operational efficiency and growth in government-sponsored healthcare programs. The company generated $163.1 billion in premium and service revenues, while adjusted diluted earnings per share (EPS) reached $7.11. This performance was anchored by a massive membership base of 28.7 million members by year-end.
According to analyst reports, the year marked a significant turnaround as the company recorded a net income of $3.8 billion, recovering from a net loss of $1.8 billion in 2024. Centene's focus on Medicaid and government programs remained central to its scale, with a reported medical cost ratio (MCR) of 87.9%, a key metric reflecting disciplined margin management and improved operational health.
While current price levels for CNC are unavailable at this snapshot, the full-year results provide a clear valuation anchor for the managed-care sector. Investors are looking ahead to macroeconomic catalysts that may influence healthcare utilization costs, noting recent market data such as Canada's inflation rate cooling to 2.8% and the U.S. Leading Index showing a slight decline of 0.2% as of July 2026.